Literature DB >> 30425444

Optimization of in vitro regeneration of Haloxylon salicornicum: a keystone species of extreme arid regions.

Deepak Krishna Vyas1, Harchand R Dagla1.   

Abstract

Haloxylon salicornicum is an economically important perennial woody shrub of family Amaranthaceae and is a good source of food additives, fodder, fuel and nutrients in Indian Thar Desert. In vitro regeneration of H. salicornicum through nodal shoot segments is achieved in present investigation. Young green shoots in horizontal orientation were found to be more responsive than vertical orientation. Axillary shoot buds were activated on MS medium containing 10 µM BAP. Adventitious roots with intense root hairs were induced on horizontally placed shoots on half strength MS medium containing 2 µM NOA + 100 mg L-1 activated charcoal. This is a first report on micropropagation of H. salicornicum. This protocol can be a useful means for in vitro characterization, mass propagation and conservation of the plant for future prospects.

Entities:  

Keywords:  Arid environment; Haloxeric; Haloxylon salicornicum; Micropropagation; Underutilized

Year:  2018        PMID: 30425444      PMCID: PMC6214444          DOI: 10.1007/s12298-018-0571-y

Source DB:  PubMed          Journal:  Physiol Mol Biol Plants        ISSN: 0974-0430


  3 in total

1.  In vitro shoot proliferation determined by explant orientation of juvenile and mature Quercus rubra L.

Authors:  A M Vieitez; F Pintos; M C San-José; A Ballester
Journal:  Tree Physiol       Date:  1993-03       Impact factor: 4.196

2.  In vitro antituberculosis activities of the constituents isolated from Haloxylon salicornicum.

Authors:  Nazia Bibi; Sheraz Ahmad K Tanoli; Sadia Farheen; Nighat Afza; Salman Siddiqi; Ying Zhang; Shahana U Kazmi; Abdul Malik
Journal:  Bioorg Med Chem Lett       Date:  2010-06-09       Impact factor: 2.823

3.  The Inhibitory Effect of Haloxylon salicornicum on Contraction of the Mouse Uterus.

Authors:  Nabila H Saleem; Valerie A Ferro; Ann M Simpson; John Igoli; Alexander I Gray; Robert M Drummond
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-23       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.